急慢性肝病患者对丙型肝炎病毒抗原的抗体模式

G.J. Padron , E. Arus , L. Rivera , Z. Rodriguez , A. Fernandez , B. Gra , L. Blitz-Dorfman
{"title":"急慢性肝病患者对丙型肝炎病毒抗原的抗体模式","authors":"G.J. Padron ,&nbsp;E. Arus ,&nbsp;L. Rivera ,&nbsp;Z. Rodriguez ,&nbsp;A. Fernandez ,&nbsp;B. Gra ,&nbsp;L. Blitz-Dorfman","doi":"10.1016/0888-0786(95)93026-8","DOIUrl":null,"url":null,"abstract":"<div><p>The present paper describes the antibody pattern in the early stages of hepatitis C virus (HCV) infection and compares it with that obtained in chronic carriers. Samples were tested for anti-HCV from 470 consecutive patients admitted to gastroenterology services at three Havana hospitals, with serological and biochemical signs of non-A, non-B hepatitis, including those referred from three Havana blood banks because of a positive result in anti-HCV in pre-donation screening. Four anti-HCV enzyme immunoassay (EIA) systems and two supplementary assays were used for antibody detection. These results show that antibodies to viral core antigens are the first and commonest among Cuban patients infected with HCV, and generally, they can reveal the infection before the supplementary tests do. LiaTek HCV has proved to be a good tool for the confirmation of enzyme-linked immunosorbent assay (ELISA) positive samples.</p></div>","PeriodicalId":101161,"journal":{"name":"Serodiagnosis and Immunotherapy in Infectious Disease","volume":"7 1","pages":"Pages 23-26"},"PeriodicalIF":0.0000,"publicationDate":"1995-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0888-0786(95)93026-8","citationCount":"2","resultStr":"{\"title\":\"Antibody pattern to hepatitis C virus antigens in patients with acute and chronic liver diseases\",\"authors\":\"G.J. Padron ,&nbsp;E. Arus ,&nbsp;L. Rivera ,&nbsp;Z. Rodriguez ,&nbsp;A. Fernandez ,&nbsp;B. Gra ,&nbsp;L. Blitz-Dorfman\",\"doi\":\"10.1016/0888-0786(95)93026-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The present paper describes the antibody pattern in the early stages of hepatitis C virus (HCV) infection and compares it with that obtained in chronic carriers. Samples were tested for anti-HCV from 470 consecutive patients admitted to gastroenterology services at three Havana hospitals, with serological and biochemical signs of non-A, non-B hepatitis, including those referred from three Havana blood banks because of a positive result in anti-HCV in pre-donation screening. Four anti-HCV enzyme immunoassay (EIA) systems and two supplementary assays were used for antibody detection. These results show that antibodies to viral core antigens are the first and commonest among Cuban patients infected with HCV, and generally, they can reveal the infection before the supplementary tests do. LiaTek HCV has proved to be a good tool for the confirmation of enzyme-linked immunosorbent assay (ELISA) positive samples.</p></div>\",\"PeriodicalId\":101161,\"journal\":{\"name\":\"Serodiagnosis and Immunotherapy in Infectious Disease\",\"volume\":\"7 1\",\"pages\":\"Pages 23-26\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1995-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0888-0786(95)93026-8\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Serodiagnosis and Immunotherapy in Infectious Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0888078695930268\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Serodiagnosis and Immunotherapy in Infectious Disease","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0888078695930268","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

摘要

本文描述了丙型肝炎病毒(HCV)感染早期的抗体模式,并将其与慢性携带者的抗体模式进行了比较。对哈瓦那三家医院胃肠科收治的470名连续患者的抗丙型肝炎病毒样本进行了检测,这些患者均有非甲、非乙型肝炎的血清学和生化体征,包括因捐献前筛查抗丙型肝炎病毒阳性结果而从哈瓦那三家血库转诊的患者。四种抗丙型肝炎病毒酶免疫测定(EIA)系统和两种补充测定法用于抗体检测。这些结果表明,针对病毒核心抗原的抗体是古巴HCV感染患者中最早和最常见的抗体,通常,它们可以在补充检测之前发现感染。LiaTek HCV已被证明是确认酶联免疫吸附试验(ELISA)阳性样品的良好工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antibody pattern to hepatitis C virus antigens in patients with acute and chronic liver diseases

The present paper describes the antibody pattern in the early stages of hepatitis C virus (HCV) infection and compares it with that obtained in chronic carriers. Samples were tested for anti-HCV from 470 consecutive patients admitted to gastroenterology services at three Havana hospitals, with serological and biochemical signs of non-A, non-B hepatitis, including those referred from three Havana blood banks because of a positive result in anti-HCV in pre-donation screening. Four anti-HCV enzyme immunoassay (EIA) systems and two supplementary assays were used for antibody detection. These results show that antibodies to viral core antigens are the first and commonest among Cuban patients infected with HCV, and generally, they can reveal the infection before the supplementary tests do. LiaTek HCV has proved to be a good tool for the confirmation of enzyme-linked immunosorbent assay (ELISA) positive samples.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信